Latest On Demand Webinars
Liver-on-Chip and In Silico Modeling for Quantitative Drug Metabolism Studies
This webinar will examine the benefits of combining LOAC with in silico modeling to explore clinical PK predictions of specific reference drugs, including investigations into the intrinsic clearance determinations for high metabolically stable compounds and the quantitation of fractions metabolized by specific enzymes.
Vaccines - Lessons Learnt From The Pandemic
In this webinar, Associate Professor Teresa Lambe will describe the development, testing and immune readout after vaccination with ChAdOx1 nCOV-19/AZD1222. The session also offers a unique opportunity to interact with Professor Lambe through a live Q&A session following her presentation.
Molecular Tools To Study Viral Infectious Diseases
Watch this webinar to learn how the evaluation of binding affinities can support viral research and assist in the identification of novel drugs.
Cytokine Profiles and Personalized Therapeutics in COVID-19 Patients
Recent observations by Prof. Gorochov’s team at the CIMI Research Centre suggest that there are at least two distinct types of cytokine signatures induced by SARS-CoV-2 infection.
Robust Metabolic Profiling for Routine Quantitation and Confident Unknown Identification
Metabolomics, the investigation of small molecules present in a biological system, finds application in diverse biomedical and industrial research. In large-scale applications, targeted profiling of metabolites is employed as it provides confident measurements for compounds of interest.
Getting a Gene Therapy Product to Market: Pitfalls and How to Prevent Them
Gene therapy is rapidly gaining importance as a critical treatment modality in the prevention or cure of a wide range of diseases. However, getting a product to market for commercial use does not come without its challenges.
Lean Manufacturing Practices with Raman Spectroscopy in Biopharmaceutical Production
In this webinar, Shailesh Karavadra, from Thermo Fisher Scientific, addresses the role of the Raman spectroscopy in the rapid release of raw materials through identity testing and real-time release testing of final products such as vaccines, hormones and monoclonal antibodies.
GMP Ancillary Materials for Cell and Gene Therapy Manufacturing
Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation.
Identifying Oligonucleotide Impurities and Metabolites With High-Resolution Mass Spectrometry
With the rapid increase in the development of oligonucleotide therapeutics and gene therapies, workflows for the identification, characterization and quantification of full-length products, their impurities and metabolites, are critical.
A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release
Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.